Q32 Bio Inc.
QTTB
Biotechnology · Healthcare
CEO, Board Member
Since 2022-01-01, last confirmed 2023-04-28
Albert Seymour
Equibles does not estimate personal net worth.
About Albert Seymour
Albert Seymour was last confirmed as CEO and Board Member at Q32 Bio Inc. (QTTB) in a filing dated April 28, 2023. The proxy statement of Q32 Bio Inc. reports total compensation of $1,197,487 for Albert Seymour in fiscal 2022, including a base salary of $527,554. Disclosed compensation is on record for 5 fiscal years.
Affiliation history
-
2022-01-01–2023-04-28
Last confirmed by a filing; no departure on record
-
Start not stated–2023-04-28
Last confirmed by a filing; no departure on record
-
Q32 Bio Inc. (QTTB)
Proxy statement
Start not stated–2022-04-29
Last confirmed by a filing; no departure on record
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Q32 Bio Inc. (QTTB) | Chief Executive Officer | $527,554 | $1,197,487 |
| 2021 | Q32 Bio Inc. (QTTB) | Chief Executive Officer | $450,000 | $1,467,658 |
| 2020 | Q32 Bio Inc. (QTTB) | Chief Scientific Officer | $426,800 | $607,577 |
| 2019 | Q32 Bio Inc. (QTTB) | Chief Scientific Officer | $405,600 | $1,876,827 |
| 2018 | Q32 Bio Inc. (QTTB) | Chief Scientific Officer | $386,948 | $2,123,757 |
Recent activity
No call appearances or filed executive changes recorded yet.